Literature DB >> 30092888

Prevalence and Clinical Significance of Respiratory Effort-Related Arousals in the General Population.

Adam Ogna1, Nadia Tobback1, Daniela Andries1, Martin Preisig2, Peter Vollenweider3, Gerard Waeber3, Pedro Marques-Vidal3, José Haba-Rubio1, Raphaël Heinzer1.   

Abstract

STUDY
OBJECTIVES: To determine the prevalence and clinical associations of respiratory effort-related arousals (RERA) in a general population sample.
METHODS: A total of 2,162 participants (51.2% women, 58.5 ± 11.0 years old, body mass index [BMI] 25.6 ± 4.2 kg/m2) of a general population-based cohort (HypnoLaus, Switzerland) underwent full polysomnography at home. Each subject with a RERA index ≥ 5 events/h was compared with an age-, sex- and apnea-hypopnea index (AHI)-matched control without RERA.
RESULTS: A RERA index ≥ 5 events/h was present in 84 participants (3.8%; 95% confidence interval: 3.2-4.8%). In 17 participants (0.8%; 95% confidence interval: 0.5-1.3%), RERAs were the predominant sleep breathing disorder and only one of them complained of excessive daytime sleepiness. Compared to matched controls, subjects with a RERA index ≥ 5 events/h were similar in terms of BMI (26.5 ± 3.5 versus 26.3 ± 4.8 kg/m2, P = .73), neck circumference (38.5 ± 3.3 versus 37.6 ± 3.7 cm, P = .10) and Epworth Sleepiness Scale score (6.7 ± 3.7 versus 6.0 ± 3.7, P = .22). Also, no differences were found for hypertension (21.4% versus 27.4%, P = .47), diabetes (7.1% versus 7.1%, P = 1.00), or metabolic syndrome (31.0% versus 23.8%, P = .39).
CONCLUSIONS: In a middle-aged population-based cohort, the prevalence of a RERA index ≥ 5 events/h was low (3.8%) and was not associated with negative clinical outcomes when using the currently recommended scoring criteria of the American Academy of Sleep Medicine.
© 2018 American Academy of Sleep Medicine.

Entities:  

Keywords:  RERA; cardiovascular risk; excessive daytime sleepiness; general population; polysomnography; sleep apnea; sleep-disordered breathing; upper airway resistance syndrome

Mesh:

Year:  2018        PMID: 30092888      PMCID: PMC6086952          DOI: 10.5664/jcsm.7268

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  26 in total

1.  Inspiratory flow limitation in a normal population of adults in São Paulo, Brazil.

Authors:  Luciana O Palombini; Sergio Tufik; David M Rapoport; Indu A Ayappa; Christian Guilleminault; Luciana B M de Godoy; Laura S Castro; Lia Bittencourt
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

2.  Sleep fragmentation as a risk factor for hypertension in middle-aged nonapneic snorers.

Authors:  F Lofaso; A Coste; L Gilain; A Harf; C Guilleminault; F Goldenberg
Journal:  Chest       Date:  1996-04       Impact factor: 9.410

Review 3.  The upper airway resistance syndrome.

Authors:  J L Pépin; M Guillot; R Tamisier; P Lévy
Journal:  Respiration       Date:  2012-03-01       Impact factor: 3.580

4.  Somatic arousal and sleepiness/fatigue among patients with sleep-disordered breathing.

Authors:  Morris S Gold; Tshering Amdo; Nadia Hasaneen; Avram R Gold
Journal:  Sleep Breath       Date:  2016-01-06       Impact factor: 2.816

5.  Hypersomnolence, insomnia and the pathophysiology of upper airway resistance syndrome.

Authors:  Avram R Gold; Morris S Gold; Keith W Harris; Vidal J Espeleta; Mohammad M Amin; Joan E Broderick
Journal:  Sleep Med       Date:  2007-11-19       Impact factor: 3.492

6.  Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome.

Authors:  Steven R Coughlin; Lynn Mawdsley; Julie A Mugarza; Peter M A Calverley; John P H Wilding
Journal:  Eur Heart J       Date:  2004-05       Impact factor: 29.983

7.  Upper airway resistance syndrome, nocturnal blood pressure monitoring, and borderline hypertension.

Authors:  C Guilleminault; R Stoohs; T Shiomi; C Kushida; I Schnittger
Journal:  Chest       Date:  1996-04       Impact factor: 9.410

8.  Reaction time performance in upper airway resistance syndrome versus obstructive sleep apnea syndrome.

Authors:  Riccardo A Stoohs; Pierre Philip; Daniela Andries; Emily V A Finlayson; Christian Guilleminault
Journal:  Sleep Med       Date:  2009-05-01       Impact factor: 3.492

9.  Diabetes mellitus prevalence and control in sleep-disordered breathing: the European Sleep Apnea Cohort (ESADA) study.

Authors:  Brian D Kent; Ludger Grote; Silke Ryan; Jean-Louis Pépin; Maria R Bonsignore; Ruzena Tkacova; Tarja Saaresranta; Johan Verbraecken; Patrick Lévy; Jan Hedner; Walter T McNicholas
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

10.  An overlooked cause of resistant hypertension: upper airway resistance syndrome - preliminary results.

Authors:  Muntecep Asker; Selvi Asker; Ugur Kucuk; Hilal Olgun Kucuk
Journal:  Clinics (Sao Paulo)       Date:  2014-11       Impact factor: 2.365

View more
  3 in total

1.  Effect of Three Hypopnea Scoring Criteria on OSA Prevalence and Associated Comorbidities in the General Population.

Authors:  Camila Hirotsu; Jose Haba-Rubio; Daniela Andries; Nadia Tobback; Pedro Marques-Vidal; Peter Vollenweider; Gérard Waeber; Raphael Heinzer
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

2.  The Evaluation of Autonomic Arousals in Scoring Sleep Respiratory Disturbances with Polysomnography and Portable Monitor Devices: A Proof of Concept Study.

Authors:  Pierre Mayer; Alberto Herrero Babiloni; Gabrielle Beetz; Serguei Marshansky; Zeina Kaddaha; Pierre H Rompré; Vincent Jobin; Gilles J Lavigne
Journal:  Nat Sci Sleep       Date:  2020-07-16

3.  Assessment of Cardiorespiratory Interactions during Apneic Events in Sleep via Fuzzy Kernel Measures of Information Dynamics.

Authors:  Ivan Lazic; Riccardo Pernice; Tatjana Loncar-Turukalo; Gorana Mijatovic; Luca Faes
Journal:  Entropy (Basel)       Date:  2021-05-31       Impact factor: 2.524

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.